TCR inhibiting SCHOOL peptides (SignaBlok)

N/A

Report date: 2025/01/26 16:06:34

Base Information

Drug NameTCR inhibiting SCHOOL peptides (SignaBlok)
Drug Alias NameT Cell Receptor Inhibitors (SignaBlok)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionT-cell receptor inhibitors
TargetsT-cell receptor
Therapy Area/IndicationsDermatitisScleroderma, SystemicArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSignaBlok Inc
China Registration ClassN/A

Develop Information

Active CompaniesSignaBlok Inc
Inactive CompaniesN/A
Active IndicationsDermatitisScleroderma, SystemicArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A